Quick verdict
Semaglutide for weight loss — the household name with cardiovascular data. Best for: People with obesity who also have cardiovascular disease or want a long track record.
Official site: Wegovy.com · FDA prescribing label (PDF) · Savings program
Pros
- Proven cardiovascular benefit (SELECT trial)
- Approved for adolescents 12+
- Once-weekly dosing
- Largest real-world evidence base
Cons
- Higher list price than Zepbound
- Less average weight loss than tirzepatide head-to-head
- Supply has been intermittent
How Wegovy works
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics gut hormones released after eating, producing three core effects (see our deeper explainer on how GLP-1s work):
- Slowed gastric emptying — food stays in your stomach longer, increasing fullness.
- Reduced appetite signaling — the drug acts on the hypothalamus to suppress hunger and food noise.
- Glucose-dependent insulin release — pancreatic beta cells release insulin only when blood sugar is elevated, lowering A1c without typical hypoglycemia.
Who Wegovy is for
People with obesity who also have cardiovascular disease or want a long track record.
FDA-approved indications:
- Chronic weight management
- Cardiovascular risk reduction in adults with obesity + CVD
Who should avoid it
- Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- History of pancreatitis
- Severe gastroparesis or inflammatory bowel disease
- Pregnancy, planning pregnancy within 2 months, or breastfeeding
- Active gallbladder disease (relative contraindication)
See our full safety guide for context on each contraindication.
How to take Wegovy
Starting dose: 0.25 mg weekly
Maximum dose: 2.4 mg weekly
- Inject subcutaneously in the abdomen, thigh, or upper arm.
- Once per week, same day each week, with or without food.
- Rotate injection sites to prevent skin irritation.
- Doses are titrated up monthly to minimize nausea — do not skip ahead.
Side effects
Common (≥5% of users):
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Headache
- Fatigue
Serious warnings:
- Boxed warning: thyroid C-cell tumors
- Pancreatitis
- Gallbladder disease
- Acute kidney injury
Most GI side effects appear during dose escalation and ease within 2–4 weeks. Eating smaller meals, avoiding greasy foods, and staying hydrated helps — our side-effect management guide covers practical tactics in detail. Persistent severe abdominal pain warrants immediate medical evaluation to rule out pancreatitis or gallbladder disease.
Where to get Wegovy
- Primary care or endocrinology: The most reliable route — your clinician handles prior authorization and monitoring.
- Telehealth platforms: Services like Ro, WW Clinic (Sequence), Form Health, and Hims/Hers prescribe FDA-approved GLP-1s after a video evaluation. Verify they prescribe the brand name, not just compounded versions.
- Direct-to-consumer: NovoCare offers savings cards and patient assistance for eligible patients. See the official Wegovy savings page.
- Avoid: Research peptides, unverified compounding pharmacies, and overseas online pharmacies. The FDA has documented counterfeit semaglutide circulating in the US supply chain.
Step-by-step pathways are covered in our guide to getting a GLP-1 prescription.
Cost
List price is approximately ~$1,349/mo. With commercial insurance and a savings card, many patients pay $0–$25/month. Without insurance, expect $500–$1,400/month depending on the program. Compare cash prices on GoodRx or Cost Plus Drugs.
Key evidence
The pivotal trial for Wegovy is SELECT (NEJM, 2023): Semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with obesity and CVD.
- FDA prescribing information (PDF) — full label, including boxed warning and trial summaries.
- ClinicalTrials.gov — active and completed studies of semaglutide
- PubMed — peer-reviewed literature on semaglutide
- The Obesity Society — clinical management of obesity
Frequently asked questions
How quickly does Wegovy work?
Most people notice reduced appetite within 1–2 weeks of starting Wegovy. Meaningful weight or A1c changes typically appear after 8–12 weeks at a therapeutic dose, with maximum effects between 6 and 18 months.
Will I regain weight if I stop Wegovy?
Clinical trials (STEP, SURMOUNT) show that most people regain a significant portion of lost weight within a year of stopping a GLP-1. These medications are generally considered long-term therapies, similar to blood pressure or cholesterol drugs.
Can I drink alcohol on Wegovy?
There is no absolute contraindication, but alcohol can worsen nausea and increase the risk of pancreatitis and hypoglycemia (especially if combined with insulin or sulfonylureas). Many patients report decreased desire for alcohol on GLP-1s.
Is Wegovy covered by insurance?
Coverage for weight loss is inconsistent. Some commercial plans cover it with a BMI requirement; Medicare currently does not cover GLP-1s purely for obesity. Manufacturer savings programs and self-pay options can reduce cost.
What happens if I miss a dose?
Take the missed dose within 5 days. If more than 5 days have passed, skip it and take the next scheduled dose. Do not double up.
Can I use Wegovy during pregnancy?
No. GLP-1 medications should be stopped at least 2 months before a planned pregnancy. They are not recommended in pregnancy or breastfeeding due to limited safety data.
Compare Wegovy to alternatives
Head-to-head guides: Ozempic vs Wegovy · Zepbound vs Wegovy. Or see the full side-by-side comparison table.
Zepbound
tirzepatide
The strongest FDA-approved weight-loss injection on the market.
Mounjaro
tirzepatide
Tirzepatide for type 2 diabetes — and the most powerful A1c reducer available.
Ozempic
semaglutide
The semaglutide brand that started the GLP-1 revolution.
Further reading
- What are GLP-1 medications? — class overview
- How GLP-1s work in the body
- Are GLP-1s safe? — risks and contraindications
- Managing GLP-1 side effects
- How to get a prescription